Generate a claims amendment document for responding to USPTO 101 subject-matter eligibility rejection in a CRISPR-Cas9 biomedical patent application

Generate generate a claims amendment document for responding to uspto 101 subject-matter eligibility rejection in a crispr-cas9 biomedical patent application for Scientific Research and Development Services industry

Scientific Research and Development Services

Agent Configuration

Login required: You need to sign in to execute this agent.

Click to upload or drag and drop

Allowed: PDF, DOCX

Max size: 10MB

Upload the complete USPTO Office Action containing the 101 subject-matter eligibility rejection for your CRISPR-Cas9 patent application

Click to upload or drag and drop

Allowed: PDF, DOCX, TXT

Max size: 5MB

Upload the current set of claims from your CRISPR-Cas9 patent application that need amendment in response to the 101 rejection
Select the specific type of 101 subject-matter eligibility rejection cited in the Office Action
Specify the biomedical application area for this CRISPR-Cas9 technology
Choose the primary approach for amending claims to overcome the 101 rejection
Indicate the experience level and specialization of the attorney preparing the amendment
Specify the current stage of development for this CRISPR therapeutic application
List 3-5 specific technical embodiments from the specification that support claim amendments for 101 compliance
Indicate which FDA regulatory pathway and standards must be considered in the amended claims
Specify the urgency and timeline requirements for this claims amendment response
Provide any company-specific technical, regulatory, or business constraints that must be considered in claim amendments